Filing Details

Accession Number:
0000939767-16-000288
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-07 19:03:49
Reporting Period:
2016-12-05
Filing Date:
2016-12-07
Accepted Time:
2016-12-07 19:03:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
939767 Exelixis Inc. EXEL Services-Commercial Physical & Biological Research (8731) 043257395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202102 A George Scangos C/O Exelixis, Inc.
210 E. Grand Ave.
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-05 357,976 $8.99 1,668,186 No 4 M Direct
Common Stock Disposition 2016-12-05 204,718 $17.81 1,463,468 No 4 S Direct
Common Stock Acquisiton 2016-12-07 356 $8.99 1,463,824 No 4 M Direct
Common Stock Disposition 2016-12-07 176 $17.90 1,463,648 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2016-12-05 357,976 $0.00 357,976 $8.99
Common Stock Option (right to buy) Disposition 2016-12-07 356 $0.00 356 $8.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
356 2007-12-08 2016-12-07 No 4 M Direct
0 2007-12-08 2016-12-07 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,963 Indirect By Trust (JS)
Common Stock 8,963 Indirect By Trust (KS)
Common Stock 5,669 Indirect By 401(k) Plan
Footnotes
  1. Includes 1,596 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
  2. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.45 to $18.00. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
  3. Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Jennifer Scangos Trust.
  4. Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Katherine Scangos Trust.
  5. Represents 5,669 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of December 2, 2016.
  6. The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became exercisable as to 100,000 shares on December 8, 2007, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the original grant date (December 8, 2006). The option ceased vesting on July 15, 2010, in connection with the Reporting Person's resignation as President and Chief Executive Officer of Exelixis, Inc., at which time the option was exercisable as to as to 358,332 shares of Exelixis, Inc. Common Stock.